文献

J-GLOBAL ID：201702272356065725   整理番号：17A1559238

Asthma(ARIA)ガイドライン2016年改訂に及ぼすアレルギー性鼻炎とその影響【Powered by NICT】

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision

著者 (68件)： Brozek Jan L. (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Brozek Jan L. (Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada) ,  Bousquet Jean (University Hospital, Montpellier, France) ,  Agache Ioana (Faculty of Medicine, Transylvania University, Brasov, Romania) ,  Agarwal Arnav (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Agarwal Arnav (School of Medicine, University of Toronto, Toronto, Ontario, Canada) ,  Bachert Claus (Upper Airways Research Laboratory, Ghent University Hospital, Ghent, Belgium) ,  Bosnic-Anticevich Sinthia (Woolcock Institute, University of Sydney, Sydney, Australia) ,  Brignardello-Petersen Romina (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Canonica G. Walter (Asthma & Allergy Clinic, Humanitas University, Rozzano, Milan, Italy) ,  Casale Thomas (Division of Allergy and Immunology, University of South Florida, Tampa, Fla) ,  Chavannes Niels H. (Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands) ,  Correia de Sousa Jaime (Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, and ICVS/3B’s-PT Government Associate Laboratory, Braga/Guimaraes, Portugal) ,  Cruz Alvaro A. (ProAR-Center of Excellence for Asthma, Federal University of Bahia, Salvador, Brazil) ,  Cuello-Garcia Carlos A. (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Demoly Pascal (University Hospital of Montpellier, Montpellier, and Sorbonne Universites, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Paris, France) ,  Dykewicz Mark (Section of Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Mo) ,  Etxeandia-Ikobaltzeta Itziar (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Etxeandia-Ikobaltzeta Itziar (Direccion de Investigacion e Innovacion Sanitaria, Departamento de Salud, Gobierno Vasco-Eusko Jaurlaritza, Vitoria-Gasteiz, Spain) ,  Florez Ivan D. (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Florez Ivan D. (Department of Pediatrics, University of Antioquia, Medellin, Colombia) ,  Fokkens Wytske (Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands) ,  Fonseca Joao (CINTESIS-Center for Health Technology and Services Research, Faculdade de Medicina, Universidade do Porto & Allergy, CUF Porto Hospital and Instituto, Porto, Portugal) ,  Hellings Peter W. (Department of Otorhinolaryngology, University Hospitals Leuven, and the Department of Otorhinolaryngology, Academic Medical Center (AMC), Amsterdam, The Netherlands) ,  Klimek Ludger (Center of Rhinology and Allergology, Wiesbaden, Germany) ,  Kowalski Sergio (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Kuna Piotr (Division of Internal Medicine Asthma and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland) ,  Laisaar Kaja-Triin (Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia) ,  Larenas-Linnemann Desiree E. (Hospital Medica Sur, Mexico City, Mexico) ,  Lodrup Carlsen Karin C. (Department of Paediatrics, Oslo University Hospital, University of Oslo, Oslo, Norway) ,  Manning Peter J. (Department of Medicine, Royal College of Surgeons in Ireland Medical School, Dublin, Ireland) ,  Meltzer Eli (Department of Pediatrics, Division of Allergy & Immunology, University of California, San Diego, Calif) ,  Mullol Joaquim (Unitat de Rinologia i Clinica de l’Olfacte, Servei d’ORL, Hospital Clinic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Spain) ,  Muraro Antonella (Department of Women and Child Health & Food Allergy Referral Centre Veneto Region, University of Padua, Padua, Italy) ,  O’Hehir Robyn (Alfred Hospital and Monash University, Melbourne, Australia) ,  Ohta Ken (National Hospital Organization Tokyo National Hospital, Kiyose-city, Tokyo, Japan) ,  Panzner Petr (Department of Immunology and Allergology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic) ,  Papadopoulos Nikolaos (Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece) ,  Papadopoulos Nikolaos (Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, United Kingdom) ,  Park Hae-Sim (Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, Korea) ,  Passalacqua Gianni (Allergy and Respiratory Diseases, IRCCS San Martino, IST, University of Genoa, Genoa, Italy) ,  Pawankar Ruby (Department of Pediatrics, Nippon Medical School, Tokyo, Japan) ,  Price David (University of Aberdeen, Aberdeen, United Kingdom) ,  Riva John J. (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Riva John J. (Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada) ,  Roldan Yetiani (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Ryan Dermot (Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom) ,  Sadeghirad Behnam (HIV/STI Surveillance Research Center, and World Health Organization Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran) ,  Samolinski Boleslaw (Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland) ,  Schmid-Grendelmeier Peter (Allergy Unit, Department of Dermatology, University Hospital of Zuerich and Christine Kuehne Center for Allergy Research and Education CK-CARE, Davos, Switzerland) ,  Sheikh Aziz (Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom) ,  Togias Alkis (Asthma and Inflammation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md) ,  Valero Antonio (Department of Pneumology and Allergy, Immunoallergia Respiratoria Clinica I Experimental (IDIBAPS), Centro de Investigaciones Biomedicas en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain) ,  Valiulis Arunas (Vilnius University Clinic of Children’s Diseases and Public Health Institute, Vilnius, and the European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium) ,  Valovirta Erkka (Department of Lung Diseases and Clinical Immunology, University of Turku and Allergy Clinic Terveystalo Turku, Turku, Finland) ,  Ventresca Matthew (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Wallace Dana (Nova Southeastern University, Fort Lauderdale, Fla) ,  Waserman Susan (Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada) ,  Wickman Magnus (Department of Pediatrics, Sachs’ Children’s Hospital, South General Hospital and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden) ,  Wiercioch Wojtek (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Yepes-Nunez Juan Jose (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Yepes-Nunez Juan Jose (School of Medicine, University of Antioquia, Medellin, Colombia) ,  Zhang Luo (Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital and Beijing Institute of Otolaryngology, Beijing, China) ,  Zhang Yuan (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Zidarn Mihaela (University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia) ,  Zuberbier Torsten (Department of Dermatology and Allergy, Charite-Universitaetsmedizin Berlin, Berlin, Germany) ,  Schuenemann Holger J. (Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada) ,  Schuenemann Holger J. (Division of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada)
資料名： Journal of Allergy and Clinical Immunology  (Journal of Allergy and Clinical Immunology)
巻： 140  号： 4  ページ： 950-958  発行年： 2017年 
JST資料番号： A0182B  ISSN： 0091-6749  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： アレルギー性鼻炎(AR)は人口の10%~40%に発症する。寿命と学校と作業パフォーマンスの品質を低下させると一般診療における診療所訪問のよくある理由である。医療コストは大きいが,失われた作業生産性に関連した回避可能なコストは喘息によるものよりも大きかった。2010年-年の喘息(ARIA)ガイドラインにアレルギー性鼻炎とその影響の最後の改訂以来,蓄積し,その更新を促進した新しい証拠。ARIAガイドラインの標的最新情報を提供しようとした。ARIAガイドラインパネルは新しい臨床質問と更新を必要とする選択した問題を同定した。健康影響の系統的レビューと患者の値と選好と資源要求(2016年6月まで)に関する証拠を行った。勧告を作成するために勧告評価,開発,and Evaluation(GRADE)証拠を意思決定フレームワークの等級づけに従った。ARIAガイドラインの2016年改訂版がARの薬理学的治療の更新と新しい勧告を提供した。特に,単独又は組合せのいずれでも,経口H_1抗ヒスタミン薬,鼻腔内H_1抗ヒスタミン薬,鼻腔内コルチコステロイドおよびロイコトリエン受容体拮抗薬を用いての相対的利点を検討した。ARIAガイドラインパネルは,治療法の選択と選択の理論的根拠に特異的な勧告を提供し,臨床医や患者は,個々の患者に最も適切な管理を選択するレビューしたいと望んでいることを特定の考慮事項を論じた。ARの適切な治療は患者のクオリティオブライフと学校と仕事の生産性を改善する可能性がある。ARIA勧告は,最適な治療を選択する患者,彼らの介護者,およびヘルスケア提供者を支持する。Copyright 2017 Elsevier B.V., Amsterdam. All rights reserved. Translated from English into Japanese by JST.【Powered by NICT】

シソーラス用語： 等級づけ ,  診療ガイドライン ,  システマティックレビュー ,  品質 ,  クオリティオブライフ ,  薬物療法 ,  喘息 ,  ロイコトリエン拮抗薬 ,  患者 ,  抗ヒスタミン薬 ,  *鼻アレルギー ,  意思決定 ,  診療所
準シソーラス用語： 健康影響 ,  *ARIA , 【Automatic Indexing@JST】

著者キーワード (2件)： アレルギー性鼻炎 ,  診療ガイドライン

分類 (1件)： 免疫性疾患・アレルギー性疾患一般  (GD04010C)

タイトルに関連する用語 (3件)： ガイドライン ,  改訂 ,  アレルギー性鼻炎